Startup & Growth Legal
Startup Regulatory Licensing and Sector Approvals
Corpus Juris Legal advises startups in regulated sectors — fintech, edtech, healthtech, insurtech, and online gaming — on the identification and procurement of mandatory regulatory licences and approvals from the RBI, SEBI, IRDAI, Ministry of Health, Department of Consumer Affairs, and state regulatory authorities, prior to product launch and fundraising.
Overview
India's regulatory landscape for technology-enabled businesses has become substantially more complex over the past five years, with sector-specific regulatory frameworks proliferating across fintech, digital lending, insurtech, online gaming, telemedicine, edtech, and the broader digital economy. Startups that fail to identify and obtain mandatory regulatory approvals before launching products face the risk of regulatory shutdown, enforcement action, and the reputational consequences that accompany public regulatory scrutiny — all of which are fatal to fundraising prospects and enterprise customer relationships. For fintech startups, the regulatory map begins with determining whether the product or service falls within the definition of regulated financial activity under the Reserve Bank of India Act 1934, the Payment and Settlement Systems Act 2007, the SEBI Act 1992, or the Insurance Act 1938. A payment aggregator requires RBI authorisation under the Payment Aggregator Guidelines 2020. A peer-to-peer lending platform requires NBFC-P2P registration. A robo-advisory product requires SEBI Investment Adviser registration under the SEBI (Investment Advisers) Regulations 2013. Account aggregators operate under a specific NBFC-AA licence framework. Corpus Juris Legal maps the product against the regulatory taxonomy with precision, identifying the mandatory licences and the product features that trigger them. For digital health startups offering telemedicine services, the Telemedicine Practice Guidelines 2020 (issued by the Board of Governors of the Medical Council of India and the Ministry of Health and Family Welfare), the Digital Information Security in Healthcare Act (currently in draft), and the DPDP Act 2023's sensitive personal data provisions collectively govern the legal environment. Pharmacy-adjacent products require Drug Controller General of India engagement. Medical device companies navigate the Medical Devices Rules 2017 under the Central Drugs Standard Control Organisation. For online gaming startups, the Online Gaming (Regulation) Act framework being implemented by the Ministry of Electronics and Information Technology, the Information Technology (Intermediary Guidelines and Digital Media Ethics Code) Amendment Rules 2023 governing online gaming intermediaries, and state-specific gaming legislation create a multi-layered regulatory environment that requires careful structural design — including the distinction between games of skill and games of chance — before product launch. Corpus Juris Legal advises startups on regulatory licensing strategy from pre-launch through post-licence compliance, managing the application process, regulatory correspondence, and ongoing compliance obligations.
Key Service Components
- ◆Fintech regulatory mapping — PSA 2007, RBI guidelines, SEBI regulations, and IRDAI framework analysis
- ◆Payment aggregator / payment gateway RBI authorisation — application preparation and RBI correspondence
- ◆NBFC licensing — NBFC-P2P, NBFC-AA, and NBFC-MFI registration applications and RBI advisory
- ◆SEBI Investment Adviser and Research Analyst registration — IA Regulations 2013 compliance
- ◆Digital health regulatory compliance — Telemedicine Guidelines 2020, CDSCO, and DPDP Act 2023
- ◆Online gaming regulatory advisory — IT Amendment Rules 2023, MeitY framework, and state law analysis
- ◆Insurtech regulatory advisory — IRDAI Bima Sugam and distribution licence requirements
- ◆DPIIT Startup India recognition — eligibility, application, and tax benefit structuring under Section 80-IAC
- ◆EdTech regulatory advisory — UGC, AICTE, and state education board regulatory requirements
- ◆Ongoing regulatory compliance management — post-licence reporting, regulatory correspondence, and renewal
Why This Matters for Your Business
A fintech startup that processes payments without RBI authorisation as a payment aggregator, or a digital lending startup that operates without NBFC registration, faces the risk of RBI enforcement action including product shutdown, customer notification requirements, and potential criminal liability for directors. Investors conducting due diligence at Series A and beyond will not proceed with a regulated fintech that has operated without mandatory licences — retrospective licensing, where even possible, creates a compliance history that depresses valuation.
Our Approach
Corpus Juris Legal approaches startup regulatory licensing with a product-first methodology — we begin by understanding what the startup's product does, how it earns revenue, and what data it processes, before mapping those activities against the applicable regulatory framework. This product-to-regulation mapping frequently reveals that the startup can restructure certain product features to reduce regulatory complexity without compromising commercial functionality — a structural choice that saves months in licensing timelines and reduces ongoing compliance burden.
Get Expert Advice
Speak directly with a partner who specialises in startup regulatory licensing and sector approvals. Free 30-minute consultation.
Request ConsultationWhatsApp NowAll Practice Areas
- Corporate & Commercial Law
- Litigation & Dispute Resolution
- Contracts & Commercial Agreements
- Intellectual Property Law
- Employment & Labour Law
- Real Estate & Property Law
- Banking, Finance & Insurance
- Tax Law
- Technology, Data & Privacy Law
- Regulatory & Compliance
- Insolvency & Restructuring
- Startup & Growth Legal